1
/
의
1
AntibodySystem
SKU(재고 관리 코드):KDJ04004
Frovocimab ELISA Kit
Frovocimab ELISA Kit
Catalog No.: KDJ04004
| Catalog No. | KDJ04004 |
|---|---|
| Product name | Frovocimab ELISA Kit |
| Size | 96 T |
| Description | PRINCIPLE OF THE ASSAY This assay employs the quantitative indirect enzyme immunoassay technique. Recombinant Human PCSK9 has been pre-coated onto a microplate. Standards or samples are pipetted into the wells and any Frovocimab present is bound by the immobilized protein. After washing away any unbound substances, a biotin-labeled Mouse Anti-Human IgG antibody is added to the wells. After washing away any unbound substances, Streptavidin-HRP is added to the wells. Following a wash to remove any unbound enzyme reagent, a substrate solution is added to the wells and color develops in proportion to the amount of Frovocimab bound in the initial step. The color development is stopped and the intensity of the color is measured. |
| Applications | Used for the quantitative determination of Frovocimab concentration in serum and plasma. |
| Stability and Storage | When the kit was stored at the recommended temperature for 6 months, the signal intensity decreased by less than 20%. |
| Detection method | Colorimetric |
| Precision | CV<15% |
| Sample type | Plasma, Serum |
| Assay type | Quantitative |
| Sensitivity | 4.31 ng/mL |
| Range | 8.78 - 100 ng/mL |
| Recovery | 80-120% |
| Background | Frovocimab (LY3015014) (INN) is a monoclonal antibody designed for the treatment of hypercholesterolemia.This drug is being developed by Eli Lilly and Company. |
| Alternative Names | LY-3015014, CAS: 1643672-70-1 |
| Shipping | 2-8 ℃ |
| Note | For Research Use Only. |
Share
